Slide 1Promoting patient-centred healthcare around the world A patient perspective on the multiple policy initiatives: Lessons learnt – assessing the gaps Joanna Groves…

1. . 03/22/15 www.PharmInfopedia.com 2. StructureThe EMEA began its activities in 1995. Decentralised body of the European Union - headquarters in London. 25 EU…

1. PHARMACOVIGILANCE IN INDIA-PRESENT & FUTURE PROSPECTS DR.NAGARAJA PRASAD.S ASSISTANT PROFESSOR DEPT OF PHARMACOLOGY S.I.M.S,SHIMOGA. 2. • PHARMACOVIGILANCE : “SCIENCE…

1. Overview of Regulatory EnvironmentOverview of Regulatory Environment in USA, Europe & Indiain USA, Europe & India Dijo Mathew JohnDijo Mathew John Pharm.D…

The History and Development of Plasma-Derived Products The BPL Experience Dr Clive Dash Medical Director BPL, Elstree A Century of Tradition The British Institute of Preventive…

Slide 1PREQUALIFICATION General overview and procedures and practical implications of WHO PQ, FDA registration, registration with PICs member countries for procurement agencies…

Slide 11 |1 | Advanced Technical Briefing Seminar : Quality Assurance and Safety of Medicines: Promoting Global Collaboration. 25–29 June 2012, WHO Headquarters, Geneva…

Slide 1 Proprietary and Confidential © AstraZeneca 2008 FOR INTERNAL USE ONLY David Cook Global Safety Assessment AstraZeneca The Application of Systems Biology to Safety…

Slide 1ADVERSE DRUG REACTIONS Prof. R. K. DIXIT Dept. of Pharmacology & Therapeutics King George’s Medical University, Lucknow [email protected] Slide 2 ADVERSE…

Slide 1 Big Pharma - The Way Forward Anders Ekblom Executive Vice President Global Drug Development Swedish-American Life Science Summit 20 th August 2009 Slide 2 Big Pharma:…